Armata Pharmaceuticals, Inc.·4

Mar 18, 8:02 PM ET

Rychlik Richard 4

4 · Armata Pharmaceuticals, Inc. · Filed Mar 18, 2024

Insider Transaction Report

Form 4
Period: 2024-03-14
Rychlik Richard
Corporate Controller and PFO
Transactions
  • Award

    Common Stock

    2024-03-14+10,00010,000 total
  • Award

    Stock Options (Right to Buy)

    2024-03-14+40,00040,000 total
    Exercise: $3.38Exp: 2034-03-14Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028.

Documents

1 file
  • 4
    tm249071-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT